These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31165076)

  • 21. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1).
    Haraki T; Yasuda T; Mukaida K; Migita T; Hamada H; Kawamoto M
    Anesth Analg; 2011 Dec; 113(6):1461-7. PubMed ID: 21926372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parental mosaicism in RYR1-related Central Core Disease.
    Marks S; van Ruitenbeek E; Fallon P; Johns P; Phadke R; Mein R; Mohammed S; Jungbluth H
    Neuromuscul Disord; 2018 May; 28(5):422-426. PubMed ID: 29576327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes.
    Zullo A; Klingler W; De Sarno C; Ferrara M; Fortunato G; Perrotta G; Gravino E; Di Noto R; Lehmann-Horn F; Melzer W; Salvatore F; Carsana A
    Hum Mutat; 2009 Apr; 30(4):E575-90. PubMed ID: 19191333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.
    Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G
    J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant or recessive mutations in the
    Galleni Leão L; Santos Souza L; Nogueira L; Pavanello RCM; Gurgel-Giannetti J; Reed UC; Oliveira ASB; Cuperman T; Cotta A; FPaim J; Zatz M; Vainzof M
    Acta Myol; 2020 Dec; 39(4):274-282. PubMed ID: 33458582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.
    Lyfenko AD; Goonasekera SA; Dirksen RT
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene.
    Fischer D; Herasse M; Ferreiro A; Barragán-Campos HM; Chiras J; Viollet L; Maugenre S; Leroy JP; Monnier N; Lunardi J; Guicheney P; Fardeau M; Romero NB
    Neurology; 2006 Dec; 67(12):2217-20. PubMed ID: 17190947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of recessive RYR1 mutations in core myopathies.
    Zhou H; Yamaguchi N; Xu L; Wang Y; Sewry C; Jungbluth H; Zorzato F; Bertini E; Muntoni F; Meissner G; Treves S
    Hum Mol Genet; 2006 Sep; 15(18):2791-803. PubMed ID: 16940308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
    Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
    Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?
    Dirksen RT; Avila G
    Trends Cardiovasc Med; 2002 Jul; 12(5):189-97. PubMed ID: 12161072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo RyR1 reduction in muscle triggers a core-like myopathy.
    Pelletier L; Petiot A; Brocard J; Giannesini B; Giovannini D; Sanchez C; Travard L; Chivet M; Beaufils M; Kutchukian C; Bendahan D; Metzger D; Franzini Armstrong C; Romero NB; Rendu J; Jacquemond V; Fauré J; Marty I
    Acta Neuropathol Commun; 2020 Nov; 8(1):192. PubMed ID: 33176865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
    Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F
    Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Dowling JJ; Lillis S; Amburgey K; Zhou H; Al-Sarraj S; Buk SJ; Wraige E; Chow G; Abbs S; Leber S; Lachlan K; Baralle D; Taylor A; Sewry C; Muntoni F; Jungbluth H
    Neuromuscul Disord; 2011 Jun; 21(6):420-7. PubMed ID: 21514828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.
    Ducreux S; Zorzato F; Müller C; Sewry C; Muntoni F; Quinlivan R; Restagno G; Girard T; Treves S
    J Biol Chem; 2004 Oct; 279(42):43838-46. PubMed ID: 15299003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.